Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Onset of Efficacy with Continuous, Subcutaneous Levodopa/carbidopa Infusion in Patients with Parkinson’s Disease Experiencing Motor Fluctuations

Author:Ellenbogen, Aaron   Stocchi, Fabrizio   Lopes, Nelson   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.012  

Author Institution:Michigan Institute for Neurological Disorders, Farmington Hills, MI  University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy  Neuroderm, Sermonde, Portugal  

Soticlestat in Vitro Metabolism and Drug-drug Interactions: Comprehensive Investigations Display Minimal Notable Interactions

Author:Cohen, Lawrence   Ballard, T. Eric   Moriya, Yuu   Nishihara, Mitsuhiro   Chuang, Bei-Ching   Ugajin, Miyuki   Hirabayashi, Hideki   Tagawa, Yoshihiko   Takahashi, Junzo   

Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P9.012  

Author Institution:Takeda Development Center Americas, Inc. , Cambridge, MA  Takeda Pharmaceutical Company Limited, Fujisawa, Japan  Former employee of Takeda Development Center Americas, Inc. , Cambridge, MA  Former employee of Takeda Pharmaceutical Company Limited, Fujisawa, Japan  

The Safety Profile of Fenebrutinib in Patients with Multiple Sclerosis Is Consistent with Those in Previously Studied Autoimmune Indications

Author:Oh, Jiwon   Raievska, Anastasiia   Sierzega, Malgorzata   Cerqueira, João   Riley, Claire S.   Caunt, Maresa   Ratchford, John N.   Goodyear, Alexandra   Vanevski, Konstantina   Sormani, Maria Pia   Giovannoni, Gavin   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.012  

Author Institution:St. Michael's Hospital, University of Toronto, Toronto, ON, Canada  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Minho, Braga, Portugal  Columbia University Medical Center, New York, NY  Genentech Inc., South San Francisco, CA  University of Genoa, Genoa, Italy  Blizard University, Queen Mary University of London, London, United Kingdom  

Neurofascin-mediated Neuropathy Mimicking Miller-Fisher Syndrome, Displaying a Broader Clinical Spectrum Inclusive of Trigeminal Autonomic Cephalalgias

Author:Ochoa Urrea, Manuela   Adesina, Ore-Ofe   Sista, Sri Raghav   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Immune Mediated Neuropathies  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.012  

Author Institution:University of Texas Health Science Center at Houston, Houston, TX  

Association of Vitamin B12 and Homocysteine with Parkinson's Disease Progression in Contemporary Trials

Author:Christine, Chadwick   Auinger, Peggy   Forti, Esther   Tat, Lyvin   Cannizzaro, Noemi   Oakes, David   Green, Ralph   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.013  

Author Institution:UCSF, San Francisco, CA  University of Rochester, Rochester, NY  University of California Davis, Davis, CA